Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies is a research paper published in Open Forum Infectious Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U54CA260591
National Institutes of Health
Grant: U01CA260584
National Institutes of Health
Grant: U01CA260469
National Institutes of Health
Grant: U54CA260543
National Institutes of Health
Grant: U54CA260560
National Institutes of Health
Grant: U01CA260541
National Institutes of Health
Grant: U01CA261277
National Institutes of Health
Grant: U01CA260526
National Institutes of Health
Grant: U01CA261276
National Institutes of Health
Grant: U01CA260539
National Institutes of Health
Grant: U01CA260513
National Institutes of Health
Grant: U01CA260507
National Institutes of Health
Grant: U01CA260462
National Institutes of Health
Grant: CBC21X089
National Institutes of Health
Grant: CBC21X090
National Institutes of Health
Grant: CBC21X091
National Institutes of Health
Grant: CBC21X092
NIMHD NIH HHS
Grant: K01 MD015079
National Institutes of Health
Grant: 1U01CA260507-01
Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic Malignancies
National Institutes of Health
Grant: 1U01CA261276-01
Enhancing racial and ethnic diversity inCOVID-19 research participation through storytelling (COVIDstory)
National Institutes of Health
Grant: 4U54CA260543-02
North Carolina Seronet Center for Excellence
National Institutes of Health
Grant: 3U54CA260582-02S3
Center for serological testing to improve outcomes from pandemic COVID-19 (STOP-COVID)
National Institutes of Health
Grant: 4U01CA260508-02
High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology
National Institutes of Health
Grant: 3U01CA260476-02S2
Immunologic Signatures of SARS-CoV-2 Vaccination and Disease
National Institutes of Health
Grant: 3U54CA260581-02S2
Tulane University COVID Antibody and Immunity Network (TUCAIN)
National Institutes of Health
Grant: 4U54CA260591-02
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2
National Institutes of Health
Grant: 3U01CA260462-02S1
Adaptive Immunity and Persistent SARS-CoV-2 Replication
National Institutes of Health
Grant: 1U01CA260584-01
SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical Use
National Institutes of Health
Grant: 3U01CA260469-02S2
Supplement to U01CA260469
National Institutes of Health
Grant: 1U01CA260541-01
SARS-CoV-2 correlates of protection in a Latino-origin population
National Institutes of Health
Grant: 3U54CA260560-02S2
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses
National Institutes of Health
Grant: 4U01CA260588-02
SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects
National Institutes of Health
Grant: 3U01CA260513-02S3
Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes.
National Institutes of Health
Grant: 4U01CA260539-02
Early Drivers of Humoral Immunity to SARS-CoV-2 Infections
National Institutes of Health
Grant: 1U54CA260563-01
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
National Institutes of Health
Grant: 1U01CA261277-01
Casual, Statistical and Mathematical Modeling with Serologic Data
National Institutes of Health
Grant: 4U54CA260492-02
Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)
National Institutes of Health
Grant: 4U01CA260526-02
DISCOVAR:Disparities in Immune Response to SARS-CoV-2 in ARkansas
National Institutes of Health
Grant: 3U54CA260517-02S2
Mechanisms and Duration of Immunity to SARS-CoV-2
Fields of Study
Keywords
Sustainable Development Goals